The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yu, Young Dong | - |
dc.contributor.author | Ko, Young Hwii | - |
dc.contributor.author | Kim, Jong Wook | - |
dc.contributor.author | Jung, Seung Il | - |
dc.contributor.author | Kang, Seok Ho | - |
dc.contributor.author | Park, Jinsung | - |
dc.contributor.author | Seo, Ho Kyung | - |
dc.contributor.author | Kim, Hyung Joon | - |
dc.contributor.author | Jeong, Byong Chang | - |
dc.contributor.author | Kim, Tae-Hwan | - |
dc.contributor.author | Choi, Se Young | - |
dc.contributor.author | Nam, Jong Kil | - |
dc.contributor.author | Ku, Ja Yoon | - |
dc.contributor.author | Joo, Kwan Joong | - |
dc.contributor.author | Jang, Won Sik | - |
dc.contributor.author | Yoon, Young Eun | - |
dc.contributor.author | Yun, Seok Joong | - |
dc.contributor.author | Hong, Sung-Hoo | - |
dc.contributor.author | Oh, Jong Jin | - |
dc.date.accessioned | 2021-11-19T10:41:01Z | - |
dc.date.available | 2021-11-19T10:41:01Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2021-05-31 | - |
dc.identifier.issn | 2234-943X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/127986 | - |
dc.description.abstract | Aim This study evaluated the prognosis and survival predictors for bladder urachal carcinoma (UC), based on large scale multicenter cohort with long term follow-up database. Methods A total 203 patients with bladder UC treated at 19 hospitals were enrolled. Clinical parameters on carcinoma presentation, diagnosis, and therapeutic methods were reviewed for the primary cancer and for all subsequent recurrences. The stage of UC was stratified by Mayo and Sheldon pathological staging system. Oncological outcomes and the possible clinicopathological parameters associated with survival outcomes were investigated. Results The mean age of the patients was 54.2 years. Among the total of 203 patients, stages I, II, III, and IV (Mayo stage) were 48 (23.8%), 108 (53.5%), 23 (11.4%), and 23 (11.4%), respectively. Gross hematuria and bladder irritation symptoms were the two most common initial symptoms. The mean follow-up period was 65 months, and 5-year overall survival rates (OS), cancer-specific survival rates (CSS), and recurrence-free survival rates (RFS) were 88.3, 83.1, and 63.9%, respectively. For the patients with Mayo stage >= III, OS, CSS, and RFS were significantly decreased to 38.0, 35.2, and 28.4%, respectively. The higher pathological stage (Mayo stage >= III, Sheldon stage >= IIIc), positive surgical margin (PSM), and positive lymphovascular invasion (PLM) were independent predictors of shorter OS, CSS, and RFS. Conclusion The pathological stage, PSM, and PLM were significantly associated with the survival of UC patients, emphasizing an importance of the complete surgical resection of tumor lesion. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.subject | SURVIVAL | - |
dc.subject | ADENOCARCINOMA | - |
dc.subject | MANAGEMENT | - |
dc.subject | CANCER | - |
dc.title | The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jong Wook | - |
dc.contributor.affiliatedAuthor | Kang, Seok Ho | - |
dc.identifier.doi | 10.3389/fonc.2021.683190 | - |
dc.identifier.scopusid | 2-s2.0-85107852462 | - |
dc.identifier.wosid | 000661186300001 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN ONCOLOGY, v.11 | - |
dc.relation.isPartOf | FRONTIERS IN ONCOLOGY | - |
dc.citation.title | FRONTIERS IN ONCOLOGY | - |
dc.citation.volume | 11 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | ADENOCARCINOMA | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordAuthor | urachal carcinoma | - |
dc.subject.keywordAuthor | bladder | - |
dc.subject.keywordAuthor | survival rate | - |
dc.subject.keywordAuthor | surgical margin | - |
dc.subject.keywordAuthor | lymphovascular invasion | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.